More from Renaissance Capital
Referenced Stocks

Stemline Therapeutics increases proposed IPO deal size

By Renaissance Capital,  January 09, 2013, 11:01:36 AM EDT

Stemline Therapeutics, a biotech developing treatments that target cancer stem cells and tumor bulk, raised the proposed deal size for its upcoming IPO on Wednesday. The New York, NY-based company now plans to raise $25 million by offering 2.3 million shares at a price range of $10 to $12. The company had previously filed to offer 1.8 million shares at a range of $10 to $12. At the midpoint of the revised range, Stemline Therapeutics will raise 25% greater proceeds than previously anticipated. 

Stemline Therapeutics, which was founded in 2003, plans to list on the NASDAQ under the symbol STML. Aegis Capital is the sole bookrunner on the deal. The company has filed to change its terms several times and had scheduled pricing dates in both July and August before ultimately delaying its offering.




The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.


This article appears in: News Headlines, IPOs

Referenced Stocks: STML



Latest News Video

5th Graders Push For Plastic Bag Ban
5th Graders Push For Plastic Bag Ba...
Twitter Rolls Out Two-Step Verification to Curb Hacking
Twitter Rolls Out Two-Step Verifica...


Sign-in
Existing NASDAQ.com member? Log in here.

By signing into to the site using any of the third-party services above, you agree to NASDAQ.com's Terms of Use.

From Our Trusted News Source





Most Active by Volume:

Company Last Sale Change Net / %
BAC $ 13.31 0.13  0.97%
PFE $ 29.30 0.52  1.81%
GE $ 23.86 0.20  0.85%
F $ 14.97 0.02  0.13%
MSFT $ 34.61 0.24  0.69%
QQQ $ 73.65 0.62  0.83%
MU $ 10.92 0.31  2.76%
INTC $ 24.07 0.08  0.33%